The NIBR Science of Therapeutics (NSofT) Symposium aims to bring interested members of the scientific community together in the spirit of open science. The virtual event will feature keynotes and talks by experts from industry and academia around a common theme, with the goal of sharing ‘hard core’ science for drug hunters to advance research and improve potential outcomes for patients.
We envision the symposium as an annual forum for the discussion of timely topics in the science of therapeutics. This year’s topic: Coronavirus Antivirals. We look forward to hosting a global audience of scientists intent on finding therapeutic solutions to this ongoing health crisis.
The symposium is free and open to the scientific community.
June 8, 9:00 AM - 3:30 PM ET Coronavirus Antivirals
Opening Remarks Jay Bradner, President, Novartis Institutes for BioMedical Research
Keynote 1 Pei-Yong Shi, PhD, University of Texas Medical Branch
Session 2 - Targeting the coronaviral main protease Annaliesa Anderson, PhD, Pfizer Nir London, PhD, Weizmann Institute of Science Stephanie Moquin, PhD, Novartis Institutes for BioMedical Research Celia Schiffer, PhD, Umass Medical School
Session 3 - Targeting the coronaviral polymerase Jay Grobler, PhD, Merck Ashleigh Shannon, PhD, University of Marseille
Session 4 - Emerging targets Rostom Ahmed-Belkacem, PhD, University of Montpellier Joseph Newman, PhD, Oxford University
Keynote 2 TBC
Closing remarks Jay Bradner, President, Novartis Institutes for BioMedical Research
A digital conference summary and video recordings of talks will be posted following the event.